Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-14T04:22:01.735Z Has data issue: false hasContentIssue false
  • English
  • Français

Does the Implementation of an Interferon-γ Release Assay in Lieu of a Tuberculin Skin Test Increase Acceptance of Preventive Therapy for Latent Tuberculosis Among Healthcare Workers?

Published online by Cambridge University Press:  02 January 2015

Rajiv Sahni ,
Cyndee Miranda ,
Belinda Yen-Lieberman ,
J. Walton Tomford ,
Paul Terpeluk ,
Pearl Quartey ,
Lucileia T. Johnson  and
Steven M. Gordon
Rajiv Sahni*
Affiliation:
Departments of Infectious Disease, Cleveland Clinic, Cleveland, Ohio
Cyndee Miranda
Affiliation:
Departments of Infectious Disease, Cleveland Clinic, Cleveland, Ohio
Belinda Yen-Lieberman
Affiliation:
Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio Lerner College of Medicine, the Cleveland Clinic, Cleveland, Ohio
J. Walton Tomford
Affiliation:
Departments of Infectious Disease, Cleveland Clinic, Cleveland, Ohio
Paul Terpeluk
Affiliation:
Occupational Health, Cleveland Clinic, Cleveland, Ohio
Pearl Quartey
Affiliation:
Lerner College of Medicine, the Cleveland Clinic, Cleveland, Ohio
Lucileia T. Johnson
Affiliation:
Departments of Infectious Disease, Cleveland Clinic, Cleveland, Ohio
Steven M. Gordon
Affiliation:
Departments of Infectious Disease, Cleveland Clinic, Cleveland, Ohio Lerner College of Medicine, the Cleveland Clinic, Cleveland, Ohio
*
Cleveland Clinic Foundation, Department of Infectious Diseases, 9500 Euclid Avenue, Mailstop S32, Cleveland, Ohio 44195 (sahnir@ccf.org)
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 2 , February 2009 , pp. 197 - 199
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Barrett-Connor, E. The epidemiology of tuberculosis in physicians. JAMA 1979;241:33–38.CrossRefGoogle ScholarPubMed
2.Ruben, FL, Norden, CW, Schuster, N. Analysis of a community hospital employee tuberculosis screening program 31 months after its inception. Am Rev Respir Dis 1997;115:23–28.Google Scholar
3.Menzies, D, Schwartzman, K. Management of latent tuberculosis infection in immigrants. N Engl J Med 2003;348:1289–1292.Google ScholarPubMed
4.Chan, JC, Tabak, JI. Risk of tuberculous infection among house staff in an urban teaching hospital. South Med J 1985;78:1061–1064.CrossRefGoogle Scholar
5.Mazurek, GH, Jereb, J, Lobue, P, et al.Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB-Gold Test for detecting Mycobacterium tuberculosis infection, United States (published correction appears in MMWR Morb Mortal Wkly Rep 2005;54:1288). MMWR Recomm Rep 2005;54(RR-15):49–55.Google Scholar
6.Fraser, TG, Kowalczyk, J, Schmitt, S, et al.Active tuberculosis in a healthcare worker: are you ready? Infect Control Hosp Epidemiol 2009;30:80–82.CrossRefGoogle Scholar
7.Parsyan, AE, Saukkonen, J, Barry, MA, Sharnprapai, S, Horsburgh, CR Jr. Predictors of failure to complete treatment for latent tuberculosis infection. J Infect 2007;54:262–266.CrossRefGoogle ScholarPubMed